RECRUITING

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated with Proton Therapy

Description

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

Conditions

Breast CarcinomaEsophageal CarcinomaGenitourinary System CarcinomaHead and Neck CarcinomaHematopoietic and Lymphoid Cell NeoplasmLung CarcinomaMalignant Central Nervous System NeoplasmMalignant Digestive System NeoplasmMalignant Solid Neoplasm
Talk to us

Related Conditions:

Breast CarcinomaEsophageal CarcinomaGenitourinary System CarcinomaHead and Neck CarcinomaHematopoietic and Lymphoid Cell NeoplasmLung CarcinomaMalignant Central Nervous System NeoplasmMalignant Digestive System NeoplasmMalignant Solid Neoplasm

Study Overview

On this page

Study Details

Study overview

This study collects information on the side effects of proton therapy and detailed information on the proton therapy treatment plan itself. This may help researchers develop methods to predict the risk of side effects for future patients and learn the long-term benefit of proton therapy.

Data Collection to Assess Acute and Late Normal Tissue Sequelae in Proton Therapy for Adults

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated with Proton Therapy

Condition
Breast Carcinoma
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All patients scheduled for radiation treatment with protons at UTMDACC are eligible for this protocol
  • * Patients must sign a study-specific consent form prior to study entry
  • * Patients who are unable or unwilling to attend the required periodic follow-ups either at M.D. Anderson or at a different site

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Steven J Frank, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2025-12-31